However, when restricting predictions to amyloid PET-positive individuals, CSF t-tau/Aβ40lumi, tau PET and CSF p-tau/Aβ40lumi were the strongest predictors of cognitive impairment followed by CSF pT217/T217. The gene discussed is MAPT; the disease is Cognitive impairment.